A Global Asset Management Seoul Korea Magazine
https://storage.scmp.com/d8/cors_uploads/2020/11/22/Travel Bubble delayed.mp4
(RTTNews) - The UK private sector contracted less than initially estimated in November despite a second lockdown, final data from IHS Markit showed Thursday. The Chartered Institute of Procurement & Supply/IHS Markit services Purchasing Managers' Index dropped to 47.6 in November from 51.4 in October. However, the score was above the flash...
WASHINGTON (REUTERS) - IBM is sounding the alarm over hackers targeting companies critical to the distribution of Covid-19 vaccines, a sign that digital spies are turning their attention to the complex logistical work involved in inoculating the world's population against the novel coronavirus. The information technology company said in a blog post published on Thursday (Dec 3) that it had uncovered "a global phishing campaign" focused on organisations associated with the Covid-19 vaccine "cold chain" - the process needed to keep vaccine doses at extremely cold temperatures as they travel from manufacturers to people's arms. The US Cybersecurity and Infrastructure Security Agency reposted the report, warning members of Operation Warp Speed - the US government's national vaccine mission - to be on the lookout. Understanding how to build a secure cold chain is fundamental to distributing vaccines developed by the likes of Pfizer and BioNTech because the shots need to be stored at minus 70 deg C or below to avoid spoiling. IBM's cyber-security unit said it had detected an advanced group of hackers working to gather information about different aspects of the cold chain, using meticulously crafted booby-trapped emails sent in the name of an executive
(RTTNews) - IP Group plc (IPO.L), a developer of intellectual property-based businesses, announced Thursday that the portfolio company Artios Pharma Ltd has entered into a global three-year strategic research collaboration with German healthcare major Merck KgaA. Under the deal, the companies plan to discover and develop multiple precision oncology drugs. As part of the agreement, Artios will receive a payment of $30 million in the form of up-front and near-term payments. If Merck chooses to exercise the option, subject to double digit option fees, Artios will be eligible to receive up to $860 million per target , in addition to up to double digit royalty payments on net sales of each product commercialised by Merck. IP Group has an 11.7% undiluted beneficial holding in Artios that was valued at 11.0 million pounds as at 30 June 2020. As a result of the collaboration, IP group directors anticipate that the company's assessment of the value of its holding in Artios may increase by 5 million pounds to 15 million pounds. Subject to certain conditions, Artios has opt-in rights for joint development and commercialization with Merck for the programmes. Artios is a DNA Damage Response or DDR company focused on developing a
BEIJING (BLOOMBERG) - The US restricted travel visas for members of the Chinese Communist Party, the latest blow to relations between the world's biggest economies. The new rules, which took effect on Wednesday (Dec 2), will allow party members and their immediate families to obtain single-entry visas, which will be limited to one month. Previously, party members could obtain multiple-entry visitor visas of as many as 10 years in duration. "The CCP and its members actively work in the US to influence Americans through propaganda, economic coercion, and other nefarious activities," a US Embassy spokesman said in an e-mailed statement. "For decades we allowed the CCP free and unfettered access to US institutions and businesses while these same privileges were never extended freely to US citizens in China." China's Communist Party has around 92 million members, including national and local government leaders. Its ranks also include millions of business people, such as China's richest man, Mr Jack Ma, co-founder of Alibaba Group, and members of the media and academia. It could also impact the children of party members, many of whom study in the US. While China Foreign Ministry spokeswoman Hua Chunying said she wasn't
Several boxes of goods, bought from JD.com, are stacked on the floor. Zhang Peng | LightRocket | Getty Images GUANGZHOU, China — JD Health, the health-care unit of Chinese e-commerce giant JD.com, has raised $3.5 billion in a Hong Kong initial public offering (IPO), CNBC has confirmed. The company issued 381.9 million shares priced at 70.58 Hong Kong dollars ($9.11) per share, according to a person familiar with the matter. That was at the top end of of the 62.8 Hong Kong dollars to 70.58 Hong Kong dollars marketed to investors, the person said. JD Health shares are expected to start trading on Dec. 8. Bloomberg first reported the details of the IPO. The listing marks another big win for the stock exchange in Hong Kong which has seen major Chinese technology firms flock there to raise money. JD Health's parent company, JD.com, carried out a secondary listing in Hong Kong in June. Another Chinese internet firm NetEase also pulled off a secondary listing in Hong Kong in June. JD.com owns around 78% of JD Health. The latter's business is focused on online health-care